SCIPHERMEDICINE, INC.

MA

Medical diagnostic company through gene expression

Filings
18
Firms Hired
1
Total Expenses
Years Active
2020–2024

Filings

YearFirmPeriodExpensesDoc
2024 HART HEALTH STRATEGIES 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Termination (No Activity)
2023 HART HEALTH STRATEGIES 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
2023 HART HEALTH STRATEGIES 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
2023 HART HEALTH STRATEGIES 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
2023 HART HEALTH STRATEGIES 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
2022 HART HEALTH STRATEGIES 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
2022 HART HEALTH STRATEGIES 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
2022 HART HEALTH STRATEGIES 2nd Quarter (Apr 1 - June 30)
AMENDED
2022 HART HEALTH STRATEGIES 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
2022 HART HEALTH STRATEGIES 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
Page 1 of 2  ·  18 filings Next
Firms Hired
FirmFilingsExpenses
HART HEALTH STRATEGIES 18
Issue Areas
IssueActivities
Health Issues 17